These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32482842)

  • 1. Clinical and radiographic course of arrested cerebral adrenoleukodystrophy.
    Mallack EJ; van de Stadt S; Caruso PA; Musolino PL; Sadjadi R; Engelen M; Eichler FS
    Neurology; 2020 Jun; 94(24):e2499-e2507. PubMed ID: 32482842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and Functional Outcomes in Boys with Cerebral Adrenoleukodystrophy with and without Hematopoietic Stem Cell Transplantation.
    Raymond GV; Aubourg P; Paker A; Escolar M; Fischer A; Blanche S; Baruchel A; Dalle JH; Michel G; Prasad V; Miller W; Paadre S; Balser J; Kurtzberg J; Nascene DR; Orchard PJ; Lund T
    Biol Blood Marrow Transplant; 2019 Mar; 25(3):538-548. PubMed ID: 30292747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.
    Pierpont EI; Eisengart JB; Shanley R; Nascene D; Raymond GV; Shapiro EG; Ziegler RS; Orchard PJ; Miller WP
    JAMA Neurol; 2017 Jun; 74(6):710-717. PubMed ID: 28418523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Spectrum of MR Imaging Patterns Suggestive of Pediatric Posterior Reversible Encephalopathy Syndrome in Children With Cerebral X-Linked Adrenoleukodystrophy.
    Ozturk K; McKinney AM
    J Neuroimaging; 2020 Nov; 30(6):930-935. PubMed ID: 32770607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five men with arresting and relapsing cerebral adrenoleukodystrophy.
    Carlson AM; Huffnagel IC; Verrips A; van der Knaap MS; Engelen M; Van Haren K
    J Neurol; 2021 Mar; 268(3):936-940. PubMed ID: 32995952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antioxidant Capacity and Superoxide Dismutase Activity in Adrenoleukodystrophy.
    Turk BR; Theisen BE; Nemeth CL; Marx JS; Shi X; Rosen M; Jones RO; Moser AB; Watkins PA; Raymond GV; Tiffany C; Fatemi A
    JAMA Neurol; 2017 May; 74(5):519-524. PubMed ID: 28288261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic stem cell transplantation in patients with childhood cerebral adrenoleukodystrophy: A single-center experience "Better prognosis in earlier stage".
    Yalcin K; Çelen SS; Daloglu H; Demir MK; Öztürkmen S; Pasayev D; Zhumatayev S; Uygun V; Hazar V; Karasu G; Yesilipek A
    Pediatr Transplant; 2021 Jun; 25(4):e14015. PubMed ID: 33780114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume of Gadolinium Enhancement and Successful Repair of the Blood-Brain Barrier in Cerebral Adrenoleukodystrophy.
    Lund TC; Ng M; Orchard PJ; Loes DJ; Raymond GV; Gupta A; Kenny-Jung D; Nascene DR
    Biol Blood Marrow Transplant; 2020 Oct; 26(10):1894-1899. PubMed ID: 32599216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI brain lesions in asymptomatic boys with X-linked adrenoleukodystrophy.
    Liberato AP; Mallack EJ; Aziz-Bose R; Hayden D; Lauer A; Caruso PA; Musolino PL; Eichler FS
    Neurology; 2019 Apr; 92(15):e1698-e1708. PubMed ID: 30902905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoperfusion predicts lesion progression in cerebral X-linked adrenoleukodystrophy.
    Musolino PL; Rapalino O; Caruso P; Caviness VS; Eichler FS
    Brain; 2012 Sep; 135(Pt 9):2676-83. PubMed ID: 22961546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Longitudinal Analysis of Early Lesion Growth in Presymptomatic Patients with Cerebral Adrenoleukodystrophy.
    Mallack EJ; Askin G; van de Stadt S; Caruso PA; Musolino PL; Engelen M; Niogi SN; Eichler FS
    AJNR Am J Neuroradiol; 2021 Oct; 42(10):1904-1911. PubMed ID: 34503945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential outcomes for frontal versus posterior demyelination in childhood cerebral adrenoleukodystrophy.
    Gupta AO; Nascene DR; Shanley R; Kenney-Jung DL; Eisengart JB; Lund TC; Orchard PJ; Pierpont EI
    J Inherit Metab Dis; 2021 Nov; 44(6):1434-1440. PubMed ID: 34499753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients.
    Miller WP; Mantovani LF; Muzic J; Rykken JB; Gawande RS; Lund TC; Shanley RM; Raymond GV; Orchard PJ; Nascene DR
    AJNR Am J Neuroradiol; 2016 Feb; 37(2):367-72. PubMed ID: 26427835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy.
    Weinhofer I; Rommer P; Gleiss A; Ponleitner M; Zierfuss B; Waidhofer-Söllner P; Fourcade S; Grabmeier-Pfistershammer K; Reinert MC; Göpfert J; Heine A; Yska HAF; Casasnovas C; Cantarín V; Bergner CG; Mallack E; Forss-Petter S; Aubourg P; Bley A; Engelen M; Eichler F; Lund TC; Pujol A; Köhler W; Kühl JS; Berger J
    EBioMedicine; 2023 Oct; 96():104781. PubMed ID: 37683329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of myelopathy in males with adrenoleukodystrophy: towards clinical trial readiness.
    Huffnagel IC; van Ballegoij WJC; van Geel BM; Vos JMBW; Kemp S; Engelen M
    Brain; 2019 Feb; 142(2):334-343. PubMed ID: 30535170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction.
    Thibert KA; Raymond GV; Nascene DR; Miller WP; Tolar J; Orchard PJ; Lund TC
    PLoS One; 2012; 7(11):e50430. PubMed ID: 23185624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of haematopoietic stem cell transplantation for adult adrenoleukodystrophy.
    Matsukawa T; Yamamoto T; Honda A; Toya T; Ishiura H; Mitsui J; Tanaka M; Hao A; Shinohara A; Ogura M; Kataoka K; Seo S; Kumano K; Hosoi M; Narukawa K; Yasunaga M; Maki H; Ichikawa M; Nannya Y; Imai Y; Takahashi T; Takahashi Y; Nagasako Y; Yasaka K; Mano KK; Matsukawa MK; Miyagawa T; Hamada M; Sakuishi K; Hayashi T; Iwata A; Terao Y; Shimizu J; Goto J; Mori H; Kunimatsu A; Aoki S; Hayashi S; Nakamura F; Arai S; Momma K; Ogata K; Yoshida T; Abe O; Inazawa J; Toda T; Kurokawa M; Tsuji S
    Brain Commun; 2020; 2(1):fcz048. PubMed ID: 32954314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report.
    Miller WP; Rothman SM; Nascene D; Kivisto T; DeFor TE; Ziegler RS; Eisengart J; Leiser K; Raymond G; Lund TC; Tolar J; Orchard PJ
    Blood; 2011 Aug; 118(7):1971-8. PubMed ID: 21586746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated cerebral spinal fluid cytokine levels in boys with cerebral adrenoleukodystrophy correlates with MRI severity.
    Lund TC; Stadem PS; Panoskaltsis-Mortari A; Raymond G; Miller WP; Tolar J; Orchard PJ
    PLoS One; 2012; 7(2):e32218. PubMed ID: 22359672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Risks to Stable Long-term Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Children With Cerebral X-linked Adrenoleukodystrophy.
    Kühl JS; Kupper J; Baqué H; Ebell W; Gärtner J; Korenke C; Spors B; Steffen IG; Strauss G; Voigt S; Weschke B; Weddige A; Köhler W; Steinfeld R
    JAMA Netw Open; 2018 Jul; 1(3):e180769. PubMed ID: 30646031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.